Compound Detail
CHEMBL48361
DABIGATRAN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL48361 |
| Name | DABIGATRAN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | YBSJFWOBGCMAKL-UHFFFAOYSA-N |
14
Targets
42
Activities
3
Assay Types
3
PK Parameters
20
Publications
5
Known Names
11
Indications
1
Mechanisms
Molecular Properties
471.5
MW (Da)
2.99
ALogP
7
HBA
4
HBD
150.2
PSA (Ų)
0.22
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Thrombin inhibitor | INHIBITOR | Prothrombin | ✓ | ✓ |
Indications
Atrial Fibrillation Hematoma Stroke Thromboembolism Venous Thromboembolism Wounds and Injuries CADASIL Hemorrhage Ischemic Stroke Renal Insufficiency Respiratory Syncytial Virus Infections
Activity Summary
IC50 22 meas. best 8.92
Ki 17 meas. best 8.35
EC50 3 meas. best 8.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prothrombin CHEMBL204 | IC50 | 8.92 | 8.4236 | 1.2 | 14 |
| Prothrombin CHEMBL204 | Ki | 8.35 | 8.3071 | 4.5 | 7 |
| Unchecked CHEMBL612545 | EC50 | 8.15 | 7.845 | 7.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.86 | 6.885 | 13.8 | 2 |
| Unchecked CHEMBL612545 | Ki | 7.3 | 7.3 | 50.0 | 1 |
| Trypsin CHEMBL2095204 | Ki | 7.3 | 7.3 | 50.0 | 2 |
| Plasma CHEMBL613424 | EC50 | 6.52 | 6.52 | 300.0 | 1 |
| Plasma CHEMBL613589 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Serine protease hepsin CHEMBL2079849 | Ki | 6.08 | 6.08 | 835.0 | 1 |
| Plasminogen CHEMBL1801 | Ki | 5.77 | 5.77 | 1695.0 | 1 |
| Coagulation factor X CHEMBL244 | Ki | 5.42 | 5.42 | 3760.0 | 2 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 5.33 | 5.33 | 4700.0 | 1 |
| Coagulation factor X CHEMBL244 | IC50 | 5.24 | 5.24 | 5800.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.09 | 5.09 | 8100.0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] CHEMBL3959 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Vitamin K-dependent protein C CHEMBL4444 | Ki | 4.68 | 4.68 | 20930.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 4.6 | 4.6 | 25300.0 | 1 |
| Tissue-type plasminogen activator CHEMBL1873 | Ki | 4.34 | 4.34 | 45360.0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] CHEMBL3959 | Ki | 4.22 | 4.22 | 60000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 6.5 | % | Homo sapiens |
| T1/2 | 0.2533 | hr | Homo sapiens |
| Tmax | 0.425 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine